
浏览全部资源
扫码关注微信
400037 重庆, 陆军军医大学(第三军医大学)第二附属医院病理科
[郭乔楠,E-mail:qiaonan85@263.netGUO Qiaonan, E-mail: qiaonan85@263.net
收稿:2022-08-05,
修回:2022-08-31,
纸质出版:2022-10-30
移动端阅览
马红敏, 郝翔麟, 吕杨帆, 等. 内皮细胞通过抑制LGI4表达激活NOTCH4信号通路促进骨肉瘤细胞转移[J]. 陆军军医大学学报, 2022,44(20):2088-2097.
Hongmin MA, Xianglin HAO, Yangfan LYU, et al. Endothelial cells promote osteosarcoma cell metastasis by inhibiting LGI4 expression and activating NOTCH4 signaling pathway[J]. Journal of Army Medical University, 2022, 44(20): 2088-2097.
马红敏, 郝翔麟, 吕杨帆, 等. 内皮细胞通过抑制LGI4表达激活NOTCH4信号通路促进骨肉瘤细胞转移[J]. 陆军军医大学学报, 2022,44(20):2088-2097. DOI: 10.16016/j.2097-0927.202208043.
Hongmin MA, Xianglin HAO, Yangfan LYU, et al. Endothelial cells promote osteosarcoma cell metastasis by inhibiting LGI4 expression and activating NOTCH4 signaling pathway[J]. Journal of Army Medical University, 2022, 44(20): 2088-2097. DOI: 10.16016/j.2097-0927.202208043.
目的
2
筛选参与内皮细胞调控骨肉瘤转移的关键分子——富亮氨酸胶质瘤失活蛋白4 (leucine-rich glioma inactivated proteins 4,LGI4),并分析LGI4参与骨肉瘤转移的功能及分子机制。
方法
2
建立人脐静脉内皮细胞(human umbilical vein endothelial cells
HUVECs)-骨肉瘤细胞共培养模型,利用全转录组测序方法并结合相关文献筛选表达差异倍数显著的基因,采用实时荧光定量PCR (real-time quantitative PCR,RT-qPCR)和Western blot验证候选基因LGI4的表达变化。转染LGI4过表达质粒建立LGI4过表达骨肉瘤稳定细胞系143B和MTF;实验分为阴性对照组(正常培养的骨肉瘤细胞)、共培养组(HUVECs与骨肉瘤细胞共培养)、共培养基组(HUVECs培养基与骨肉瘤细胞共培养)、载体对照组(转染过表达对照载体)和LGI4组(转染过表达LGI4载体),采用Transwell和划痕实验检测骨肉瘤细胞的迁移、侵袭能力。利用裸鼠体内转移模型验证LGI4对骨肉瘤细胞远处转移的影响;采用生物信息学分析LGI4的下游潜在靶信号通路,并利用相关抑制剂进行回复实验,明确靶信号通路在LGI4调控骨肉瘤转移中的作用。
结果
2
人骨肉瘤细胞系143B及MTF与HUVECs共培养后LGI4表达降低(
P
<
0.05);与阴性对照组相比,共培养组和共培养基组的迁移侵袭能力明显增加,而LGI4组的迁移侵袭能力较载体对照组比较明显减弱(
P
<
0.05)。裸鼠体内实验证明LGI4组的转移能力受到抑制;进一步分析发现NOTCH4信号通路是LGI4的下游靶信号通路,功能回复实验证实LGI4通过抑制NOTCH4信号通路参与骨肉瘤转移(
P
<
0.05)。
结论
2
内皮细胞通过抑制骨肉瘤细胞LGI4表达激活NOTCH4信号通路促进肿瘤转移。
Objective
2
To screen a key molecule
leucine-rich glioma inactivated protein 4 (LGI4)
which participates in endothelial cell-mediated osteosarcoma metastasis
and to further analyze its function and molecular mechanism in osteosarcoma metastasis.
Methods
2
A co-culture model of human umbilical vein endothelial cells (HUVECs)-osteosarcoma cells was established
and the genes with significant fold change were screened by whole transcriptome sequencing in combination with relevant
literature. After
the candidate target gene
LGI4 was verified with real-time quantitative PCR (RT-qPCR) and Western blotting
the expression of LGI4 at mRNA and protein levels was also determined. Osteosarcoma cell line 143B and MTF LGI4 were transfected with the overexpression plasmid of LGI4 to construct the cells with stable overexpression of LGI4. Then the experiments included 5 groups of osteosarcoma cells
including negative control group (normally cultured)
co-culture group (co-cultured with HUVECs)
co-culture medium group (treated with the HUVECs medium)
vector control group (transfected with control plasmid) and LGI4 group (overexpression of LGI4). Transwell assay and wound healing test were used to detect the migration and invasion abilities of osteosarcoma cells. A tumor metastasis model in nude mice was used to verify the effect of LGI4 overexpressed osteosarcoma cells on distant metastasis
in vivo
. Bioinformatics analysis was applied to analyze the potential downstream target signaling pathways of LGI4
and recovery experiments were performed with related inhibitors to clarify the role of target signaling pathways in the regulation of osteosarcoma metastasis by LGI4.
Results
2
The expression levels of LGI4 were markedly decreased in 143B and MTF cells after co-culture with HUVECs (
P
<
0.05). Compared with the negative control group
the cell migration and invasion abilities of the co-culture group and co-medium group were significantly enhanced
whereas the cell migration and invasion rates of the LGI4 overexpression group were significantly lower than that of the vector control group (
P
<
0.05). The nude mice metastasis model revealed that the metastasis ability of osteosarcoma cells was suppressed with LGI4 overexpression. Further analysis revealed that NOTCH4 signaling pathway was the downstream target signaling pathway of LGI4
and functional recovery experiments confirmed that LGI4 resulted in osteosarcoma
metastasis by inhibiting NOTCH4 signaling pathway (
P
<
0.05).
Conclusion
2
Endothelial cells activate NOTCH4 signaling pathway and thus promote tumor metastasis by inhibiting the expression of LGI4 in osteosarcoma cells.
GILL J, GORLICK R. Advancing therapy for osteosarcoma[J]. Nat Rev Clin Oncol, 2021, 18(10): 609-624. DOI: 10.1038/s41571-021-00519-8.
YANG B S, LI L T, TONG G, et al . Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis[J ] . J Exp Clin Cancer Res, 2021, 40(1): 235. DOI: 10.1186/s13046-021-02027-0.
LIU Y, HUANG N G, LIAO S J, et al . Current research progress in targeted anti-angiogenesis therapy for osteosarcoma[J ] . Cell Prolif, 2021, 54(9): e13102. DOI: 10.1111/cpr.13102.
MAISHI N, ANNAN D A, KIKUCHI H, et al . Tumor endo thelial heterogeneity in cancer progression[J ] . Cancers (Basel), 2019, 11(10): E1511. DOI: 10.3390/cancers11101511.
MAISHI N, HIDA K. Tumor endothelial cells accelerate tumor metastasis[J]. Cancer Sci, 2017, 108(10): 1921-1926. DOI: 10.1111/cas.13336.
HERRANZ-PÉREZ V, OLUCHA-BORDONAU F E, MORANTE-REDOLAT J M, et al . Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain[J ] . Brain Res, 2010, 1307: 177-194. DOI: 10.1016/j.brainres.2009.10.013.
KEGEL L, AUNIN E, MEIJER D, et al . LGI proteins in the nervous system[J ] . ASN Neuro, 2013, 5(3): 167-181. DOI: 10.1042/AN20120095.
GU W L, WEVERS A, SCHRÖDER H, et al . The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins[J ] . FEBS Lett, 2002, 519(1/2/3): 71-76. DOI: 10.1016/s0014-5793(02) 02713-8.
SAGANE K, ISHIHAMA Y, SUGIMOTO H. LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11[J]. Int J Biol Sci, 2008, 4(6): 387-396. DOI: 10.7150/ijbs.4.387.
CHERNOVA O B, SOMERVILLE R P, COWELL J K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors[J]. Oncogene, 1998, 17(22): 2873-2881. DOI: 10.1038/sj.onc.1202481.
JOKINEN T S, METSÄHONKALA L, BERGAMASCO L, et al . Benign familial juvenile epilepsy in Lagotto Romagnolo dogs[J ] . J Vet Intern Med, 2007, 21(3): 464-471. DOI: 10.1892/0891-6640(2007)21[464:bfjeil ] 2.0.co;2.
KIM D S, KWON N S, YUN H Y. Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non-small cell lung cancer[J]. Oncol Lett, 2019, 18(3): 3388-3398. DOI: 10.3892/ol.2019.10648.
BOOTH D G, KOZAR N, BRADLEY S, et al . Characterizing the molecular etiology of arthrogryposis multiplex congenita in patients with LGI4 mutations[J ] . Glia, 2021, 69(11): 2605-2617. DOI: 10.1002/glia.24061.
XUE S F, MALUENDA J, MARGUET F, et al . Loss-of-function mutations in LGI4, a secreted ligand involved in schwann cell myelination, are responsible for arthrogryposis multiplex congenita[J ] . Am J Hum Genet, 2017, 100(4): 659-665. DOI: 10.1016/j.ajhg.2017.02.006.
NISHINO J, SAUNDERS T L, SAGANE K, et al . LGI4 promotes the proliferation and differentiation of glial lineage cells throughout the developing peripheral nervous system[J ] . J Neurosci, 2010, 30(45): 15228-15240. DOI: 10.1523/JNEUROSCI.2286-10.2010.
COSTA E T, BARNABÉ G F, LI M, et al . Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals[J ] . Oncogene, 2015, 34(10): 1270-1279. DOI: 10.1038/onc.2014.70.
FIORAMONTI M, FAUSTI V, PANTANO F, et al . Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment[J ] . Sci Rep, 2018, 8(1): 4177. DOI: 10.1038/s41598-018-22469-5.
CORRE I, VERRECCHIA F, CRENN V, et al . The osteosarcoma microenvironment: a complex but targetable ecosystem[J ] . Cells, 2020, 9(4): E976. DOI: 10.3390/cells9040976.
PELELI M, MOUSTAKAS A, PAPAPETROPOULOS A. Endothelial-tumor cell interaction in brain and CNS malignancies[J]. Int J Mol Sci, 2020, 21(19): 7371. DOI: 10.3390/ijms21197371.
ROSSI M R, HUNTOON K, COWELL J K. Differential expression of the LGI and SLIT families of genes in human cancer cells[J]. Gene, 2005, 356: 85-90. DOI: 10.1016/j.gene.2005.04.018.
LUO Y B, SUN F L, PENG X W, et al . Integrated bioinformatics analysis to identify abnormal methylated differentially expressed genes for predicting prognosis of human colon cancer[J ] . Int J Gen Med, 2021, 14: 4745-4756. DOI: 10.2147/IJGM.S324483.
马博, 田志华, 曲莉, 等. 索拉菲尼诱导的肝癌耐药细胞株的建立及基因表达分析[J]. 北京大学学报(医学版), 2020, 52(2): 207-213. DOI: 10.19723/j.issn.1671-167x.2020.02.003:
MA B, TIAN Z H, QU L, et al . Establishment and gene expression analysis of drug-resistant cell lines in hepatocellular carcinoma induced by sorafenib[J ] . J Peking Univ Heal Sci, 2020, 52(2): 207-213. DOI: 10.19723/j.issn.1671-167X.2020.02.003.
TANG X F, CAO Y, PENG D B, et al . Overexpression of Notch3 is associat ed with metastasis and poor prognosis in osteosarcoma patients[J ] . Cancer Manag Res, 2019, 11: 547-559. DOI: 10.2147/CMAR.S185495.
ZHANG Z X, BU X, YANG J Y, et al . NOTCH 4 regulates colorectal cancer proliferation, invasiveness, and determines clinical outcome of patients[J ] . J Cell Physiol, 2018, 233(10): 6975-6985. DOI: 10.1002/jcp.26619..
LI W J, XIE X X, BAI J, et al . Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis[J ] . Eur Rev Med Pharmacol Sci, 2018, 22(23): 8374-8382. DOI: 10.26355/eurrev_201812_16535.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621